Chelsea L Shover1,2, Matthew R Beymer2,3, Erin M Unger2, Marjan Javanbakht1, Robert K Bolan2. 1. 1 Department of Health and Mental Health Services, Los Angeles LGBT Center , Los Angeles, California. 2. 2 Department of Epidemiology, Fielding School of Public Health, University of California , Los Angeles, Los Angeles, California. 3. 3 Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California , Los Angeles, Los Angeles, California.
Abstract
PURPOSE: This study analyzed the accuracy of presumptive gonorrhea treatment in a sexual health clinic serving primarily gay, bisexual, and other men who have sex with men (MSM). Treating suspected gonorrhea before laboratory confirmation can reduce symptoms and transmission; however, this strategy can overtreat uninfected individuals, which may promote antimicrobial resistance. We identified differences in accuracy of gonorrhea presumptive treatment by site of infection and presence of signs or symptoms. METHODS: We conducted a cross-sectional study of gay, bisexual, and other MSM who were treated presumptively for gonorrhea at the Los Angeles LGBT Center between February and July 2015. We calculated positivity of treated patients, proportion of infections treated, and positive predictive value (PPV) of treating gonorrhea presumptively based on signs, symptoms, or exposure at the urethral, rectal, or pharyngeal site. RESULTS: Of 9141 testing visits, presumptive treatment was provided at 1677 (18%). Overall, gonococcal infections were identified at 31% (n = 527) of visits where presumptive treatment was provided, compared to 9% (n = 657) of visits without presumptive treatment (P < 0.01). Forty-five percent of gonococcal infections were treated presumptively, and treatment was provided at 14% of gonorrhea-negative visits. Seventy-eight percent of urethral, 54% of rectal, and 35% of pharyngeal infections were treated presumptively. PPV was highest for genitourinary signs. CONCLUSION: Approximately one-third of gay, bisexual, or other MSM treated presumptively for gonorrhea at a sexual health clinic tested positive for gonorrhea. These findings highlight the potential contribution of point-of-care tests in reducing overtreatment resulting from presumptive treatment.
PURPOSE: This study analyzed the accuracy of presumptive gonorrhea treatment in a sexual health clinic serving primarily gay, bisexual, and other men who have sex with men (MSM). Treating suspected gonorrhea before laboratory confirmation can reduce symptoms and transmission; however, this strategy can overtreat uninfected individuals, which may promote antimicrobial resistance. We identified differences in accuracy of gonorrhea presumptive treatment by site of infection and presence of signs or symptoms. METHODS: We conducted a cross-sectional study of gay, bisexual, and other MSM who were treated presumptively for gonorrhea at the Los Angeles LGBT Center between February and July 2015. We calculated positivity of treated patients, proportion of infections treated, and positive predictive value (PPV) of treating gonorrhea presumptively based on signs, symptoms, or exposure at the urethral, rectal, or pharyngeal site. RESULTS: Of 9141 testing visits, presumptive treatment was provided at 1677 (18%). Overall, gonococcal infections were identified at 31% (n = 527) of visits where presumptive treatment was provided, compared to 9% (n = 657) of visits without presumptive treatment (P < 0.01). Forty-five percent of gonococcal infections were treated presumptively, and treatment was provided at 14% of gonorrhea-negative visits. Seventy-eight percent of urethral, 54% of rectal, and 35% of pharyngeal infections were treated presumptively. PPV was highest for genitourinary signs. CONCLUSION: Approximately one-third of gay, bisexual, or other MSM treated presumptively for gonorrhea at a sexual health clinic tested positive for gonorrhea. These findings highlight the potential contribution of point-of-care tests in reducing overtreatment resulting from presumptive treatment.
Entities:
Keywords:
bisexual; clinical research; epidemiology; gay; men who have sex with men; sexually transmitted infections
Authors: Charlotte K Kent; Janice K Chaw; William Wong; Sally Liska; Steven Gibson; Gregory Hubbard; Jeffrey D Klausner Journal: Clin Infect Dis Date: 2005-05-26 Impact factor: 9.079
Authors: Katherine C Scott; Susan Philip; Katherine Ahrens; Charlotte K Kent; Jeffrey D Klausner Journal: J Acquir Immune Defic Syndr Date: 2008-05-01 Impact factor: 3.731
Authors: Belma Andric; Joanna Drowos; Mary Jo Trepka; Gabriel Suciu; Alina Alonso; Charles H Hennekens Journal: South Med J Date: 2013-05 Impact factor: 0.954
Authors: Gerald L Murray; Catriona S Bradshaw; Melanie Bissessor; Jennifer Danielewski; Suzanne M Garland; Jørgen S Jensen; Christopher K Fairley; Sepehr N Tabrizi Journal: Emerg Infect Dis Date: 2017-05 Impact factor: 6.883
Authors: Dongdong Jiang; Yitan Hou; Xiangfan Chen; Rui Wang; Chang Fu; Baojing Li; Lei Jin; Thomas Lee; Xiaojun Liu Journal: Int J Environ Res Public Health Date: 2019-06-08 Impact factor: 3.390